IDSA 2020巴贝虫病诊断与管理临床实践指南
美国感染病学会(IDSA)发布2020年巴贝虫病诊断与管理指南,旨在为诊断和治疗提供循证建议。指南面向基层医生及感染科、急诊、重症、内科、儿科、血液科和输血医学等专科医生。巴贝虫与莱姆病共感染的诊治另见IDSA/AAN/ACR联合指南,人粒细胞无形体病诊治参见CDC立克次体病指南。
要点
- 本指南提供巴贝虫病诊断与管理的循证建议。
- 目标读者包括基层医生及相关专科医生。
- 巴贝虫与莱姆病共感染诊治另见其他指南。
核心结论
- 指南旨在为巴贝虫病诊断和治疗提供最有效策略的循证指导。
研究设计与样本
- 美国感染病学会(IDSA)制定,方法学细节原文未报告。
临床怎么用
- 面向诊治巴贝虫病的基层医生及感染科、急诊、重症、内科、儿科、血液科、输血医学等专科医生。
局限性
- 巴贝虫与莱姆病共感染诊治未纳入本指南,另见IDSA/AAN/ACR联合指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this guideline is to provide evidence-based guidance for the most effective strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co-infection with babesiosis and Lyme disease will be addressed in a separate Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) guideline [1]. Recommendations for the diagnosis and treatment of human granulocytic anaplasmosis can be found in the recent rickettsial disease guideline developed by the Centers for Disease Control and Prevention [2]. The target audience for the babesiosis guideline includes primary care physicians and specialists caring for this condition, such as infectious diseases specialists, emergency physicians, intensivists, internists, pediatricians, hematologists, and transfusion medicine specialists.
引用
- Krause PJ, Auwaerter PG, Bannuru RR, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clin Infect Dis. 2021. PMID: 33501959. doi:10.1093/cid/ciab050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。